• Info
  • Insider Ownership

Insider Trading & Ownership of Matthew Winton

Location
Boston, MA
Summary
The estimated net worth of Matthew Winton is at least $304K dollars as of November 19, 2025. Matthew Winton is the COO of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $185K. Matthew Winton is the Chief Commercial and Business of CervoMed Inc. and owns shares of CervoMed Inc. (CRVO) stock worth about $119K.
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
All Insider Reports
All Insider Reports

Notify me when Matthew Winton files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Matthew Winton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INZY Inozyme Pharma, Inc. Coo $185K Jul 1, 2025
CRVO CervoMed Inc. Chief Commercial and Business $119K +$117K +5525% Nov 17, 2025

Insider Transactions Reported by Matthew Winton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.